Physician
Pathology
Dr. Thomas R. Fritsche, MD
|
|
Give Review
Thomas Fritsche is an expert in the field of Pathology. He studied medicine at University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care Dr. Thomas R. Fritsche is a published doctor and has 100 publications published. The lastest was: 'Appearances are Deceptive: Staphylococcus Superinfection of Clavicular Tuberculous Osteomyelitis.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Appearances are Deceptive: Staphylococcus Superinfection of Clavicular Tuberculous Osteomyelitis.
- Comparison of a Real-time PCR Method with Serology and Blood Smear Analysis for Diagnosis of Human Anaplasmosis: Importance of Infection Time Course for Optimal Test U...
- Flap Infection Associated with Medicinal Leeches in Reconstructive Surgery: Two New Drug-Resistant Organisms.
- Evidence of multiple virulence subtypes in nosocomial and community-associated MRSA genotypes in companion animals from the upper midwestern and northeastern United St...
- Preparation of corneal donor eyes comparing 1% versus 5% povidone-iodine.
- Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
- Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
- Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler's diarrhea.
- Case report of Aurantimonas altamirensis bloodstream infection.
- Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.
- Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates.
- Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acq...
- Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.
- In vitro potency evaluations of various piperacillin/tazobactam generic products compared with the contemporary branded (Zosyn, Wyeth) formulation.
- Detection of methyltransferases conferring high-level resistance to aminoglycosides in enterobacteriaceae from Europe, North America, and Latin America.
- Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
- Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the...
- Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates.
- Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers.
- In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
- RmtD 16S RNA methylase in epidemiologically unrelated spm-1-producing Pseudomonas aeruginosa isolates from Brazil.
- Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
- Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
- Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteri...
- Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.
- LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
- WITHDRAWN: Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.
- Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent.
- Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
- Agar dilution and disk diffusion susceptibility testing of Campylobacter spp.
- Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveilla...
- Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial survei...
- In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
- Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with ele...
- Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
- Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
- Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United ...
- The role of newer orally administered cephalosporins in contemporary outpatient practice.
- Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
- Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Pr...
- Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
- Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004).
- Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003).
- Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Inform...
- Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrob...
- Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemothera...
- Comparison of dalbavancin MIC values determined by Etest (AB BIODISK) and reference dilution methods using gram-positive organisms.
- Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased suscept...
- Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.
- Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance ...
- Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).
- International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003).
- Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in th...
- Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lact...
- Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes.
- Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
- Microbiologic characterization of isolates from a dalbavancin clinical trial for catheter-related bloodstream infections.
- Carbapenem susceptibility discords among Acinetobacter isolates.
- Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
- Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
- Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
- Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents.
- Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio tes...
- Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus.
- Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.
- Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.
- Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
- Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
- Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
- Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
- Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
- Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicr...
- Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
- Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
- Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
- Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.
- Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels.
- Emerging epidemic of metallo-beta-lactamase-mediated resistances.
- Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).
- Comparative activity of oral and parenteral cephalosporins tested against multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillan...
- Evaluation of alternative disk diffusion methods for detecting mecA-mediated oxacillin resistance in an international collection of staphylococci: validation report fr...
- Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
- Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates.
- Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
- Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program.
- Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy.
- In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutane...
- Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
- Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
- Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates.
- Babesia divergens-like infection, Washington State.
- Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.
- Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory trac...
- Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and ...
- NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America.
- Counting leukocytes in expressed prostatic secretions from patients with chronic prostatitis/chronic pelvic pain syndrome.
- Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
- Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.
- Laboratory diagnosis of Trypanosoma cruzi infection in a colony-raised pigtailed macaque.
Schools
University of Mn Med Sch
Doctors Specialties
- Clinical Pathology
- Pathology
Accepted Insurances
- Choice Plus POS II
- American Family Insurance
- American Republic
- Medicare MCR
- United Healthcare
Education
-
University of Washington -
University of Minnesota Medical School
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285885624 |
| Last Name Of The Provider | FRITSCHE |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
|
Dr. Chris T. Waldo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yeping Sun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Syed M. Sajjad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald J. Schreiber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gene R. Shaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald H. Spirek, MD
This Doctor is OpenDoctor Recommended.
|